A Multicenter, Randomized, Double-blind, Parallel-group, Clinical Study of S-649266 Compared With Meropenem for the Treatment of Hospital-acquired Bacterial Pneumonia, Ventilator-associated Bacterial Pneumonia, or Healthcare-associated Bacterial Pneumonia Caused by Gram-negative Pathogens
Phase of Trial: Phase III
Latest Information Update: 23 May 2018
At a glance
- Drugs Cefiderocol (Primary) ; Linezolid; Meropenem
- Indications Gram-negative infections; Nosocomial pneumonia
- Focus Registrational; Therapeutic Use
- Acronyms APEKS-NP
- Sponsors Shionogi
- 23 May 2018 Study design presented at the 114th International Conference of the American Thoracic Society
- 17 Mar 2018 This trial has been changed from Suspended to recruiting in Spain, according to European Clinical Trials Database record.
- 01 Dec 2017 This trial has been Suspended in Spain, according to European Clinical Trials Database record.